KraneShares MSCI All China Health Care Index ETF (KURE)
NYSEARCA: KURE · Real-Time Price · USD
14.82
-0.41 (-2.69%)
Jun 5, 2026, 4:00 PM EDT - Market closed
KURE Holdings Information
KURE is an equity ETF with a total of 49 individual holdings. The top holdings are BeOne Medicines AG stock at 9.27%, Innovent Biologics at 8.40%, WuXi Biologics at 7.94%, WuXi AppTec at 5.76%, and Shenzhen Mindray Bio-Medical Electronics at 4.36%.
Total Holdings
49
Top 10 Percentage
55.27%
Asset Class
Equity
ETF Category
Greater China Region
Assets
68.54M
PE Ratio
24.10
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | HKG: 6160 | BeOne Medicines AG | 9.27% |
| 2 | HKG: 1801 | Innovent Biologics, Inc. | 8.40% |
| 3 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 7.94% |
| 4 | SHA: 603259 | WuXi AppTec Co., Ltd. | 5.76% |
| 5 | SHE: 300760 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 4.36% |
| 6 | SHA: 600276 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 4.33% |
| 7 | HKG: 9926 | Akeso, Inc. | 4.24% |
| 8 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 3.90% |
| 9 | HKG: 1177 | Sino Biopharmaceutical Limited | 3.55% |
| 10 | HKG: 2359 | WuXi AppTec Co., Ltd. | 3.52% |
| 11 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 2.83% |
| 12 | SHA: 688271 | Shanghai United Imaging Healthcare Co., Ltd. | 2.45% |
| 13 | HKG: 1530 | 3SBio Inc. | 2.33% |
| 14 | SHE: 000538 | Yunnan Baiyao Group Co.,Ltd | 2.31% |
| 15 | SHE: 300015 | Aier Eye Hospital Group Co., Ltd. | 2.11% |
| 16 | SHA: 600436 | Zhangzhou Pientzehuang Pharmaceutical., Ltd. | 1.95% |
| 17 | HKG: 1099 | Sinopharm Group Co. Ltd. | 1.77% |
| 18 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 1.66% |
| 19 | LEGN | Legend Biotech Corporation | 1.46% |
| 20 | SHE: 002422 | Sichuan Kelun Pharmaceutical Co., Ltd. | 1.44% |
| 21 | SHA: 688506 | Sichuan Biokin Pharmaceutical Co.,Ltd. | 1.40% |
| 22 | HKG: 2268 | WuXi XDC Cayman Inc. | 1.34% |
| 23 | SHE: 000963 | Huadong Medicine Co., Ltd | 1.30% |
| 24 | SHA: 600196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1.23% |
| 25 | HKG: 1548 | Genscript Biotech Corporation | 1.20% |
As of Jun 4, 2026